Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results

被引：11
|
作者：
Pereyra-Rodriguez, J. J. [1 ,17 ]
Herranz, P. [2 ]
Figueras-Nart, I [3 ]
Perez, B. [4 ]
Elosua, M. [5 ]
Munera-Campos, M. [6 ]
Melgosa-Ramos, J. [7 ]
Zaragoza, V [8 ]
Silvestre, J. F. [9 ]
Campos-Dominguez, M. [10 ]
Guilabert, A. [11 ]
Miquel, J. [12 ]
Alcantara-Luna, S. [13 ]
de la Cueva, P. [14 ]
Serra-Baldrich, E. [15 ]
Armario-Hita, J. C. [16 ]
Rodriguez, Jose Juan Pereyra
机构：
[1] Univ Hosp Virgen Rocio, Dept Dermatol, Seville, Spain
[2] Univ Hosp La Paz, Dept Dermatol, Madrid, Spain
[3] Univ Hosp Bellvitge, Dept Dermatol, Barcelona, Spain
[4] Univ Hosp Ramon & Cajal, Dept Dermatol, Madrid, Spain
[5] Univ Hosp Puerta Hierro, Dept Dermatol, Madrid, Spain
[6] Univ Hosp Germans Trias i Pujol, Dept Dermatol, Badalona, Spain
[7] Univ Hosp Doctor Peset, Dept Dermatol, Valencia, Spain
[8] Univ Hosp Gen Valencia, Dept Dermatol, Valencia, Spain
[9] Univ Hosp Alicante, Dept Dermatol, Alicante, Spain
[10] Univ Hosp Gregorio Maranon, Dept Dermatol, Madrid, Spain
[11] Gen Hosp Granollers, Dept Dermatol, Barcelona, Spain
[12] Univ Hosp Arnau Vilanova, Dept Dermatol, Valencia, Spain
[13] Juan Ramon Jimenez Hosp, Dept Dermatol, Huelva, Spain
[14] Infanta Leonor Hosp, Dept Dermatol, Madrid, Spain
[15] St Pau Hosp, Dept Dermatol, Barcelona, Spain
[16] Univ Hosp Puerto Real, Dept Dermatol, Puerto Real, Spain
[17] Univ Hosp Virgen del Roci, Dept Dermatol, Avda Manuel Siurot S-N, Seville 41013, Spain
来源：
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 2023年 / 33卷 / 03期
关键词：
Atopic dermatitis; Atopic eczema; Upadacitinib; JAK-inhibitors; Real-world evidence; DOUBLE-BLIND; ADOLESCENTS; PLACEBO; ADULTS;
D O I：
10.18176/jiaci.0831
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：211 / 213
页数：3
相关论文
共 50 条
  • [21] The efficacy and immunological effects of upadacitinib in the treatment of moderate-to-severe Chinese atopic dermatitis patients
    Li, Lu
    Wu, Naming
    Liu, Tingyu
    Yu, Guoqun
    Wang, Yifei
    He, Ting
    Mao, Raymond
    Yang, Liu
    Li, Yan
    Shen, Chen
    Tao, Juan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
  • [22] Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review
    Lytvyn, Yuliya
    Mufti, Asfandyar
    Abduelmula, Abrahim
    Sachdeva, Muskaan
    Maliyar, Khalad
    Georgakopoulos, Jorge R.
    Yeung, Jensen
    PHARMACEUTICS, 2022, 14 (11)
  • [23] Short-Term Evaluation of the Real-World Efficacy and Safety of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis: A Canadian Multicenter Retrospective Cohort Study
    Jo, Christine E.
    Georgakopoulos, Jorge R.
    Ladda, Matthew
    Ighani, Arvin
    Mufti, Asfandyar
    Drucker, Aaron M.
    Piguet, Vincent
    Yeung, Jensen
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2020, 24 (05) : 468 - 473
  • [24] Efficacy and safety of baricitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    JOURNAL OF DERMATOLOGY, 2023, 50 (07): : 869 - 879
  • [25] Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment
    Armstrong, April
    Blauvelt, Andrew
    Simpson, Eric L.
    Smith, Catherine H.
    Herranz, Pedro
    Kataoka, Yoko
    Seo, Seong Jun
    Ferrucci, Silvia M.
    Chao, Jingdong
    Chen, Zhen
    Rossi, Ana B.
    Shumel, Brad
    Tomondy, Paul
    DERMATOLOGY AND THERAPY, 2022, 12 (01) : 195 - 202
  • [26] Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment
    April Armstrong
    Andrew Blauvelt
    Eric L. Simpson
    Catherine H. Smith
    Pedro Herranz
    Yoko Kataoka
    Seong Jun Seo
    Silvia M. Ferrucci
    Jingdong Chao
    Zhen Chen
    Ana B. Rossi
    Brad Shumel
    Paul Tomondy
    Dermatology and Therapy, 2022, 12 : 195 - 202
  • [27] Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis
    BerthJones, J
    GrahamBrown, BAC
    Marks, B
    Camp, RDR
    English, JSC
    Freeman, K
    Holden, CA
    Rogers, SCF
    Oliwiecki, S
    Friedmann, PS
    LewisJones, MS
    Archer, CB
    Adriaans, B
    Douglas, WS
    Allen, BR
    BRITISH JOURNAL OF DERMATOLOGY, 1997, 136 (01) : 76 - 81
  • [28] Network meta-analysis on the efficacy and safety of upadacitinib in adolescents and adults with moderate-to-severe atopic dermatitis
    Qiu, Mei
    Duan, Xue-Yan
    Yin, Dao-Gen
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (01) : E24 - E26
  • [29] Dual efficacy of upadacitinib in a patient with concomitant severe atopic dermatitis and alopecia areata
    Walls, B.
    Reguiai, Z.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2023, 150 (04): : 281 - 283
  • [30] Clinical and pharmacokinetic results of upadacitinib in Chinese healthy subjects and subjects with moderate-to-severe atopic dermatitis
    Zheng, Min
    Zhang, Chunlei
    Fang, Hong
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB30 - AB30
12345